Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

The effectiveness of breast cancer screening by mammography in younger women.

Elwood JM, Cox B, Richardson AK.

Online J Curr Clin Trials. 1993 Feb 25;Doc No 32:[23,227 words; 195 paragraphs]. Erratum in: Online J Curr Clin Trials. 1994 Mar 31;Doc No 121:[385 words; 4 paragraphs]. Online J Curr Clin Trials 1993 Mar 5;Doc No 34:[295 words; 2 paragraphs].

PMID:
8305999
2.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

3.

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age.

Black WC, Nease RF Jr, Tosteson AN.

J Natl Cancer Inst. 1995 May 17;87(10):720-31.

PMID:
7563149
5.

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ.

J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23.

PMID:
7563167
7.

Report of the International Workshop on Screening for Breast Cancer.

Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S.

J Natl Cancer Inst. 1993 Oct 20;85(20):1644-56.

PMID:
8105098
8.

Mammography in symptomatic and asymptomatic patients.

Stomper PC, Gelman RS.

Hematol Oncol Clin North Am. 1989 Dec;3(4):611-40. Review.

PMID:
2691492
9.

Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.

Frisell J, Lidbrink E, Hellström L, Rutqvist LE.

Breast Cancer Res Treat. 1997 Sep;45(3):263-70.

PMID:
9386870
10.

Breast cancer screening.

Sirovich BE, Sox HC Jr.

Surg Clin North Am. 1999 Oct;79(5):961-90. Review.

PMID:
10572546
11.

Screening younger women at risk for breast cancer.

Vogel VG.

J Natl Cancer Inst Monogr. 1994;(16):55-60. Review.

PMID:
7999470
12.

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

Miller AB, Baines CJ, To T, Wall C.

CMAJ. 1992 Nov 15;147(10):1459-76. Erratum in: Can Med Assoc J 1993 Mar 1;148(5):718.

13.

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

Miller AB, Baines CJ, To T, Wall C.

CMAJ. 1992 Nov 15;147(10):1477-88. Erratum in: Can Med Assoc J 1993 Mar 1;148(5):718.

14.

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Humphrey LL, Helfand M, Chan BK, Woolf SH.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60.

PMID:
12204020
15.
16.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

17.

Should we recommend screening mammography for women aged 40 to 49?

Esserman L, Kerlikowske K.

Oncology (Williston Park). 1996 Mar;10(3):357-64; discussion: 370-6. Review.

18.

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.

Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A.

Lancet. 1999 Jun 5;353(9168):1903-8.

PMID:
10371567
19.

Maximizing the benefits of screening mammography for women 40-49 years old.

Bastardis-Zakas K, Iatrakis G, Navrozoglou I, Peitsidis P, Salakos N, Malakassis P, Zervoudis S.

Clin Exp Obstet Gynecol. 2010;37(4):278-82.

PMID:
21355457
20.

Mammographic screening of women aged 40 to 49 years. Is it justified?

Feig SA.

Obstet Gynecol Clin North Am. 1994 Dec;21(4):587-606. Review.

PMID:
7731636

Supplemental Content

Support Center